Ward Michael James 4
4 · BioNano Genomics, Inc · Filed Oct 3, 2018
Insider Transaction Report
Form 4
Ward Michael James
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-10-01+59,590→ 59,590 totalExercise: $7.77Exp: 2028-09-30→ Common Stock (59,590 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on October 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.